Gene Patents Draw High Court Review in Biotechnology Test

The U.S. Supreme Court agreed to consider whether human genes can be patented, taking up an issue that has split the medical community and will shape the future of personalized health care and the biotechnology industry.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.